Hepatitis B eradication: vaccine as a key player.
Hepatitis B virus
adverse effects
eradication
vaccine coverage
vaccine hesitancy
Journal
American journal of translational research
ISSN: 1943-8141
Titre abrégé: Am J Transl Res
Pays: United States
ID NLM: 101493030
Informations de publication
Date de publication:
2023
2023
Historique:
received:
03
05
2023
accepted:
26
07
2023
medline:
11
9
2023
pubmed:
11
9
2023
entrez:
11
9
2023
Statut:
epublish
Résumé
Despite the availability of a highly effective and safe vaccine against hepatitis B virus (HBV) infection for 40 years, still almost 300 million persons are estimated to be chronically infected by this virus worldwide. The World Health Organization (WHO) has proposed a plan for hepatitis elimination by 2030. However, several factors, such as the reduction and limitation in vaccination campaigns or vaccine hesitancy (VH) in some regions of the World, might have played a role in limiting the worldwide coverage of hepatitis B prophylaxis. This review aims to describe which factors, such as VH, may be hampering the WHO 2030 goal for hepatitis B eradication. The review describes the development and characteristics of the HBV vaccine, from the first plasma-derived to the recombinant one. Eventual limitations in its effectiveness and particularly VH were reviewed. The apparent pitfalls of the HBV vaccine, such as long-term effectiveness, vaccine-escape mutants, and adverse effects, were proven not to be a concern for this vaccine. However, VH persists and was even intensified by the COVID-19 pandemic. Many barriers still exist, such as vaccine availability, lack of awareness of the benefits of HBV vaccination, and VH. HBV VH seems to be eventually overcome in many settings with active education campaigns and information, stressing the importance of developing these strategies to achieve the 2030 goal of the WHO.
Types de publication
Journal Article
Review
Langues
eng
Pagination
4971-4983Informations de copyright
AJTR Copyright © 2023.
Déclaration de conflit d'intérêts
None.
Références
Int J Epidemiol. 2016 Apr;45(2):441-9
pubmed: 27174834
Vaccine. 2020 Jan 29;38(5):1144-1151
pubmed: 31810781
J Public Health Manag Pract. 2022 Jul-Aug 01;28(4):417-424
pubmed: 35389958
Bull Cancer. 2021 Jan;108(1):90-101
pubmed: 33358507
BMC Infect Dis. 2018 Jun 1;18(1):251
pubmed: 29859062
Int J Womens Health. 2022 Aug 17;14:1093-1104
pubmed: 35999868
Braz J Infect Dis. 2017 Sep - Oct;21(5):515-519
pubmed: 28579170
Am J Epidemiol. 2022 Aug 22;191(9):1626-1635
pubmed: 35292806
Am J Infect Control. 2020 Apr;48(4):368-374
pubmed: 31753548
Rev Saude Publica. 2012 Aug;46(4):665-73
pubmed: 22735274
Rev Soc Bras Med Trop. 2016 Feb;49(1):11-23
pubmed: 26689276
BioDrugs. 1998 Jul;10(1):11-25
pubmed: 18020583
Med Microbiol Immunol. 2015 Feb;204(1):57-68
pubmed: 25557605
Rev Panam Salud Publica. 2017 Dec 20;41:e159
pubmed: 31391841
Vaccines (Basel). 2022 May 17;10(5):
pubmed: 35632549
Clin Res Hepatol Gastroenterol. 2020 Nov;44(6):825-835
pubmed: 32553521
Open Forum Infect Dis. 2022 Apr 07;9(5):ofac175
pubmed: 35531381
Front Public Health. 2019 Oct 25;7:304
pubmed: 31709217
Vaccines (Basel). 2022 Jul 14;10(7):
pubmed: 35891285
Expert Opin Drug Saf. 2022 Mar;21(3):295-302
pubmed: 34787536
Cold Spring Harb Perspect Med. 2015 May 01;5(5):a021410
pubmed: 25934461
Rev Saude Publica. 2003 Jun;37(3):333-8
pubmed: 12792684
PLoS Negl Trop Dis. 2018 Aug 6;12(8):e0006629
pubmed: 30080852
Hepatology. 1999 Sep;30(3):779-86
pubmed: 10462386
MMWR Morb Mortal Wkly Rep. 2022 Nov 04;71(44):1396-1400
pubmed: 36327156
EBioMedicine. 2015 Jun 23;2(8):891-7
pubmed: 26425696
Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1837-1843
pubmed: 27488435
Hum Vaccin Immunother. 2020;16(2):251-268
pubmed: 31809638
Arq Gastroenterol. 2017 Dec;54(4):356-358
pubmed: 28724049
Wkly Epidemiol Rec. ;92(27):369-92
pubmed: 28685564
Clin Infect Dis. 1995 Apr;20(4):992-1000
pubmed: 7795104
PLoS One. 2019 Oct 14;14(10):e0223733
pubmed: 31609983
Vaccines (Basel). 2022 Nov 25;10(12):
pubmed: 36560423
Clin Microbiol Infect. 2017 May;23(5):311-317
pubmed: 27599689
Cancer Lett. 2022 Jun 28;536:215652
pubmed: 35318115
Hum Vaccin Immunother. 2015;11(1):53-7
pubmed: 25483515
Glob Health Sci Pract. 2022 Mar 1;10(1):
pubmed: 35294376
Rev Lat Am Enfermagem. 2013 Sep-Oct;21(5):1030-8
pubmed: 24142210
Rev Epidemiol Sante Publique. 2022 Feb;70(1):25-30
pubmed: 35164982
Clin Infect Dis. 2011 Jul 1;53(1):68-75
pubmed: 21653306
Isr J Health Policy Res. 2021 Aug 23;10(1):49
pubmed: 34425894
JAMA Netw Open. 2021 Oct 1;4(10):e2128652
pubmed: 34636914
Lancet. 1990 Aug 11;336(8711):325-9
pubmed: 1697396
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):796-829
pubmed: 35738290
Hepatol Commun. 2022 May;6(5):1005-1015
pubmed: 34918868
Rev Bras Epidemiol. 2015 Jul-Sep;18(3):552-67
pubmed: 26247181
Vaccine. 2016 Dec 7;34(50):6229-6235
pubmed: 27817958
Aliment Pharmacol Ther. 2016 Nov;44(10):1005-1017
pubmed: 27630001
Cien Saude Colet. 2021 Mar;26(3):1173-1182
pubmed: 33729369
Expert Rev Vaccines. 2011 Dec;10(12):1709-15
pubmed: 22085174
Lancet. 1988 Nov 12;2(8620):1132-3
pubmed: 2460710
Expert Rev Vaccines. 2020 May;19(5):419-443
pubmed: 32419537
Front Public Health. 2020 Jul 28;8:361
pubmed: 32850592
Hum Vaccin Immunother. 2021 Dec 02;17(12):5579-5584
pubmed: 34757865
Transfus Med. 2023 Feb;33(1):81-89
pubmed: 36815535
Rev Saude Publica. 2018 Nov 29;52:96
pubmed: 30517523
J Gen Virol. 1978 Feb;38(2):339-50
pubmed: 627876
Vaccine. 2020 Sep 11;38(40):6215-6223
pubmed: 32741674
Hum Vaccin Immunother. 2017 May 4;13(5):998-1004
pubmed: 27937074
Lancet Glob Health. 2019 Sep;7(9):e1180-e1188
pubmed: 31353061
World J Hepatol. 2015 Aug 28;7(18):2127-32
pubmed: 26328023
Int J Environ Res Public Health. 2022 Dec 06;19(23):
pubmed: 36498435
PeerJ. 2018 Feb 16;6:e4297
pubmed: 29472994
Infect Dis Now. 2020 Oct 12;51(2):153-158
pubmed: 33059002
Vaccine. 2022 Aug 5;40(33):4889-4896
pubmed: 35810058
Isr Med Assoc J. 2020 Mar;22(3):148-153
pubmed: 32147978
Gastroenterology. 2016 Sep;151(3):472-480.e1
pubmed: 27269245
J Infect. 2019 Feb;78(2):134-139
pubmed: 30292782
J Community Health. 2020 Feb;45(1):63-72
pubmed: 31392603
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
Vaccines (Basel). 2021 Jul 10;9(7):
pubmed: 34358187
Vaccine X. 2021 Oct 19;9:100118
pubmed: 34746744
Euro Surveill. 2018 Apr;23(17):
pubmed: 29717693
Aust N Z J Obstet Gynaecol. 2020 Feb;60(1):93-100
pubmed: 31259386
Viruses. 2022 Jul 11;14(7):
pubmed: 35891495
Cureus. 2022 Oct 5;14(10):e29941
pubmed: 36348919
Lancet. 1991 Nov 9;338(8776):1174-5
pubmed: 1682594
J Gen Virol. 2020 Mar;101(3):271-283
pubmed: 32134374
Vaccine. 2020 Jul 22;38(34):5541-5547
pubmed: 32620373
Stud Hist Philos Biol Biomed Sci. 2017 Aug;64:11-21
pubmed: 28511068
Lancet. 2023 Mar 25;401(10381):1039-1052
pubmed: 36774930
Hepatology. 2011 Sep 2;54(3):801-7
pubmed: 21618565
Virol J. 2013 Jul 20;10:239
pubmed: 23870415
MEDICC Rev. 2021 Jan;23(1):21-29
pubmed: 33780419
Curr Opin Virol. 2021 Dec;51:149-157
pubmed: 34710645
Emerg Infect Dis. 2022;28(13):S217-S224
pubmed: 36502399
J Pediatric Infect Dis Soc. 2021 Dec 31;10(12):1080-1086
pubmed: 34402910
Drugs. 2023 Apr;83(5):367-388
pubmed: 36906663
Trans R Soc Trop Med Hyg. 2022 Apr 4;116(4):359-368
pubmed: 34453162